Section Arrow
JANX.NASDAQ
- Janux Therapeutics
Quotes are at least 15-min delayed:2025/07/15 17:43 EDT
After Hours
Last
 25.4
-0.36 (-1.40%)
Bid
24
Ask
29.9
High 25.76 
Low 25.4 
Volume 13787 
Regular Hours
Last
 25.76
-0.42 (-1.60%)
Day High 
26.665 
Prev. Close
26.18 
1-M High
26.39 
Volume 
794.93K 
Bid
24
Ask
29.9
Day Low
25.285 
Open
26.65 
1-M Low
22.54 
Market Cap 
1.55B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 24.57 
20-SMA 23.98 
50-SMA 24.99 
52-W High 71.71 
52-W Low 22.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.36/-2.59
Enterprise Value
1.57B
Balance Sheet
Book Value Per Share
17.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.59M
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
KAPAKairos Pharma Ltd.1.17+0.4849+70.78%-- 
After Hours 1.07 -0.1 -8.55%
NCNANuCana plc0.0502+0.0043+9.37%-- 
After Hours 0.0515 +0.0013 +2.59%
PLRZPolyrizon Ltd1.04+0.3579+52.47%-- 
After Hours 0.9598 -0.0802 -7.71%
CYCCCyclacel Pharmaceuticals Inc12.33+9.02+272.51%0.08PE
After Hours 9.26 -3.07 -24.90%
IOVAIovance Biotherapeutics1.94-0.07-3.48%-- 
After Hours 1.88 -0.06 -3.09%
Quotes are at least 15-min delayed:2025/07/15 17:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T CellEngagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with atumor antigen-binding domain and a costimulatory CD28 binding domain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.